Department of Psychiatry, University Hospital of Copenhagen, Denmark.
Psychopathology. 2010;43(3):197-204. doi: 10.1159/000304176. Epub 2010 Apr 6.
It has never been investigated whether comorbid personality disorder or neuroticism predicts a poor treatment outcome in first episode depression.
Medically treated patients discharged with a diagnosis of a single depressive episode from a psychiatric in- or outpatient hospital setting were consecutively sampled from the Danish Psychiatric Central Research Register. The patients participated in an extensive interview including the Schedules for Clinical Assessment in Neuropsychiatry, the Structured Clinical Interview for DSM-IV Axis II Personality Disorders and a detailed assessment of medical treatment history using standardised procedures (Treatment Response to Antidepressants Questionnaire, TRAQ). Remission was defined as a score of < or =7 on the Hamilton Depression Rating Scale, 17 items, and a score of > or =4 on the TRAQ following (1) a first adequate trial of antidepressant treatment, and (2) 2 trials of antidepressant treatment. Further personality traits were assessed by means of the Eysenck Personality Questionnaire.
Among a total of 301 patients with a single depressive episode, 31.9% fulfilled diagnostic criteria for at least 1 personality disorder of any kind. Comorbid personality disorder was associated with a 2.2-times (95% CI: 1.1-4.2) increased risk of non-remission following the first antidepressant trial, whereas no effect was found following the second antidepressant trial (OR: 1.6; 95% CI: 0.8-3.4). A high level of neuroticism was associated with non-remission in first as well as second trials.
Comorbid personality disorder and high levels of neuroticism in first episode depression predict an increased risk of non-remission from depression.
尚未研究共病人格障碍或神经质是否预示首发抑郁症的治疗结果不佳。
从丹麦精神病学中央研究登记处连续抽取精神科门诊或住院患者,这些患者经医学治疗后出院,诊断为单次抑郁发作。患者参与了一项广泛的访谈,包括临床评估神经精神病学时间表、DSM-IV 轴 II 人格障碍的结构化临床访谈以及使用标准程序(抗抑郁药治疗反应问卷,TRAQ)详细评估医疗治疗史。缓解定义为汉密尔顿抑郁评定量表 17 项的评分<或=7,TRAQ 的评分>或=4,以下列方式(1)首次充分的抗抑郁治疗试验和(2)2 次抗抑郁治疗试验。通过艾森克人格问卷进一步评估人格特质。
在总共 301 例单发性抑郁发作的患者中,31.9%符合至少 1 种任何类型人格障碍的诊断标准。共病人格障碍与首次抗抑郁试验后无缓解的风险增加 2.2 倍(95%可信区间:1.1-4.2),而第二次抗抑郁试验后无影响(OR:1.6;95%可信区间:0.8-3.4)。神经质水平高与首次和第二次试验均无缓解有关。
首发抑郁症中存在共病人格障碍和高水平神经质可预测抑郁缓解率降低。